| Name | Title | Contact Details |
|---|
SynGen advances regenerative medicine and other emerging applications for high-value cells by providing researchers, clinicians and manufacturers with innovative, robust systems that improve the recovery, purity and viability of stem and other clinically important cells from umbilical cord blood, peripheral blood, bone marrow, and cell culture.
ALTA GENETICS INC. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Watertown, WI. To find more information about ALTA GENETICS INC., please visit www.altagenetics.com
EKOS Corporation was founded in 1995 with the vision that ultrasound could accelerate the delivery of drugs to benefit patients with a variety of diseases and conditions. Today, EKOS is the world leader in providing ultrasound-assisted, fluid infusion
For more than 100 years, VNA Health Group`s visiting nurses of NJ have made a difference in people`s lives Compassionate, caring, patient-centered, home- and community-based care delivered to you by people who take the time to know you, not just your medical history. We bring advanced care to where you`re most comfortable and can heal the fastest— in your home or wherever you reside. Each year, as the largest, non-profit visiting nurse association in New Jersey, our inter-disciplinary team provide services to more than 120,000 of your neighbors and friends, perhaps even you or someone you love. We are proud to know that we help make our community a healthier place. Whether it`s providing care for children with special needs or in-home care for seniors, we can help.
StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery primarily in the United States. Its lead therapeutic product candidate, HuCNS-SC cells (purified human neural stem cells), is in development as a potential treatment for a range of central nervous system disorders. The company has conducted a Phase I clinical trial in Pelizaeus-Merzbacher disease, a fatal myelination disorder in children. It is also conducting a Phase I/II clinical trial in chronic spinal cord injury; and has initiated a Phase I/II clinical trial in dry age-related macular degeneration, as well as is pursuing preclinical studies in Alzheimer’s disease. In addition, the company markets a rage of proprietary cell culture products, research grade human cells, and antibody reagents under the SC Proven brand. The proprietary cell culture products include iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff227, NDiff N2, and NDiff N27 supplements, as well as HEScGRO and ESGRO Complete; and antibody reagents comprise STEM24, STEM101, STEM121, and STEM123, which can be used for cell detection, isolation, and characterization. Further, StemCells is involved in developing and commercializing applications of its technologies to enable stem cell-based research. The company sells its tools and technologies products to researchers at academic institutions, pharmaceutical and biotechnology companies, and government laboratories. StemCells, Inc. was founded in 1988 and is headquartered in Newark, California.